STAND.
COM. REP. NO. 1073
Honolulu, Hawaii
, 2023
RE: H.B. No. 70
H.D. 2
Honorable Scott K. Saiki
Speaker, House of Representatives
Thirty-Second State Legislature
Regular Session of 2023
State of Hawaii
Sir:
Your Committee on Judiciary & Hawaiian Affairs, to which was referred H.B. No. 70, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO CONTROLLED SUBSTANCES,"
begs leave to report as follows:
The purpose of this measure is to:
(1) Prohibit the sale and distribution of hemp products that contain cannabinoids created through isomerization, including Delta 6 cis or trans tetrahydrocannabinol, and their optical isomers;
(2) Exempt certain cannabis and manufactured cannabis product sales from the prohibition; and
(3) Insert alternative names for Delta 6 cis or trans tetrahydrocannabinol and their optical isomers into the list of schedule I controlled substances.
Your Committee finds that hemp products containing cannabinoids created through isomerization, including Delta-8 tetrahydrocannabinol have not been approved by the United States Food and Drug Administration for safe use in any context. Your Committee further finds that existing interim rules adopted by the Department of Health ban such hemp products. This measure will codify the ban to ensure the welfare and safety of residents.
Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Judiciary & Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 70, H.D. 1, as amended herein, and recommends that it pass Third Reading in the form attached hereto as H.B. No. 70, H.D. 2.
Respectfully submitted on behalf of the members of the Committee on Judiciary & Hawaiian Affairs,
|
|
|
____________________________ DAVID A. TARNAS, Chair |
|
|
|
|